Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer

Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer

IntroductionOral mucositis (OM) is a main side effect of treatment for head and neck cancer (HNC) and causes severe pain, reduces quality of life, and may interrupt HNC treatment. This study assessed the activity and feasibility of benzydamine mouthwash in the prevention and treatment of radiation-i...

Full description

Bibliographic Details
Main Authors: Paolo Bossi, Valeria Tellone, Giorgio Di Loreto, Sara Fioravanti, Enrica Salvatori, Alessandro Comandini
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
head and neck cancer (HNC)
benzydamine
oral mucositis (OM)
prevention
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1345129/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1345129/full

Similar Items